Gina Cavalier Joins Arnold & Porter’s Life Sciences & Healthcare Regulatory Practice in Los Angeles
LOS ANGELES, July 6, 2023 — Arnold & Porter announced today that Gina Cavalier has joined the firm’s Life Sciences & Healthcare Regulatory practice as a partner, resident in Los Angeles. Over the past year, Arnold & Porter’s Life Sciences group was named a Practice Group of the Year by Law360 for its sustained commitment to providing creative and integrated support for the industry in critical regulatory, transactional, and litigation matters.
Allison Shuren, co-chair of Arnold & Porter’s Life Sciences & Healthcare Regulatory practice, said: “Gina’s strong experience handling fraud and abuse cases coupled with her focus on medical device and health-care provider matters will add further dimension to our stellar healthcare practice. In particular, Gina has distinguished herself as a go-to attorney to help clients navigate through their most challenging and complex matters.”
Sean Morris, head of Arnold & Porter’s Los Angeles office, added: “Gina is a fantastic addition to the Los Angeles office and her arrival reflects our ongoing investment in the firm’s over 30-year presence on the West Coast. Gina further strengthens our foothold in the West and expands our existing team of talented lawyers both in California and nationwide.”
A seasoned fraud and abuse and compliance lawyer, Cavalier’s practice focuses on guiding life sciences entities through complex healthcare laws and regulations and providing clients with innovative solutions and strategic advice on their most important business concerns. Cavalier has particular experience in advising clients on issues arising from the Anti-Kickback Statute, as well as other federal and state anti-fraud authorities. She also helps clients structure and manage financial arrangements with customers and healthcare professionals. Additionally, Cavalier advises life sciences companies on data privacy issues, including building compliance programs under the Health Insurance Portability and Accountability Act (HIPAA), and related regulations including the Privacy, Security, and Breach Notification Rules.
In joining the firm, Cavalier commented: “I am delighted to join Arnold & Porter’s synergistic Life Sciences & Healthcare Regulatory practice, which is renowned for its comprehensive and integrated capabilities advising clients in all aspects of the life sciences and healthcare fields. I look forward to working with the brilliant team to help our clients navigate the complex, highly regulated healthcare industry landscape.”
Cavalier earned her J.D., cum laude, from Georgetown University and received her B.A. from Boston University, with distinction, summa cum laude, Phi Beta Kappa. She has been recognized by Chambers USA and LMG Life Sciences as a leading healthcare lawyer.
Cavalier’s arrival follows the recent expansion of the firm’s U.S. and European life sciences regulatory footprints with the opening of the Amsterdam office and the arrival of partners Carla Schoonderbeek and Bart Jong in August 2022, as well as the addition of partner Liz Lindquist in Denver and counsel Monique Nolan in Washington, D.C. The firm also bolstered its life sciences IP and life sciences transactions teams in New York with partners Abigail Struthers, Betty Yan, and Niket Rele.
About Arnold & Porter
Arnold & Porter combines sophisticated regulatory, litigation, and transactional capabilities to resolve clients’ most complex issues. With over 1,000 lawyers practicing in 14 offices worldwide, we offer deep industry experience and an integrated approach that spans more than 40 practice areas. Through multidisciplinary collaboration and focused industry experience, we provide innovative and effective solutions to mitigate risks, address challenges, and achieve successful outcomes.
